Evidence map›Paper›PMID 32486030›Full record

ArticleMetabolites2020

Restoration of Physiological Levels of Uric Acid and Ascorbic Acid Reroutes the Metabolism of Stored Red Blood Cells.

Manon Bardyn, Jingkui Chen, Michaël Dussiot, David Crettaz, Lucas Schmid, Emmanuel Längst, Pascal Amireault, Jean-Daniel Tissot, Mario Jolicoeur, Michel Prudent

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Manon BardynLaboratoire de Recherche sur les Produits Sanguins, Transfusion Interrégionale CRS, CH-1066 Epalinges, Switzerland.ORCID 0000-0003-0051-8232
Jingkui ChenDépartement de Génie Chimique, École Polytechnique de Montréal, P.O. Box 6079, Centre-Ville Station, Montréal, QC H3C 3A7, Canada.
Michaël DussiotINSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, INTS, Université de Paris, 75015 Paris, France.ORCID 0000-0002-6804-1621
David CrettazLaboratoire de Recherche sur les Produits Sanguins, Transfusion Interrégionale CRS, CH-1066 Epalinges, Switzerland.
Lucas SchmidLaboratoire de Recherche sur les Produits Sanguins, Transfusion Interrégionale CRS, CH-1066 Epalinges, Switzerland.ORCID 0000-0002-4043-2962
Emmanuel LängstLaboratoire de Recherche sur les Produits Sanguins, Transfusion Interrégionale CRS, CH-1066 Epalinges, Switzerland.
Pascal AmireaultINSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, INTS, Université de Paris, 75015 Paris, France.
Jean-Daniel TissotCentre de Transfusion Sanguine, Faculté de Biologie et de Médicine, Université de Lausanne, CH-1011 Lausanne, Switzerland.ORCID 0000-0003-2493-8469
Mario JolicoeurDépartement de Génie Chimique, École Polytechnique de Montréal, P.O. Box 6079, Centre-Ville Station, Montréal, QC H3C 3A7, Canada.ORCID 0000-0002-0875-7265
Michel PrudentLaboratoire de Recherche sur les Produits Sanguins, Transfusion Interrégionale CRS, CH-1066 Epalinges, Switzerland.ORCID 0000-0001-9470-0179
Service Régional Vaudois de Transfusion Sanguine · CHInserm · FRPolytechnique Montréal · CAUniversity of Lausanne · CH

Funding

CETRASA foundation New routes and new additive solution formulations to improve the quality of stored red blood cells
6 · The paper itself

Abstract

After blood donation, the red blood cells (RBCs) for transfusion are generally isolated by centrifugation and then filtrated and supplemented with additive solution. The consecutive changes of the extracellular environment participate to the occurrence of storage lesions. In this study, the hypothesis is that restoring physiological levels of uric and ascorbic acids (major plasmatic antioxidants) might correct metabolism defects and protect RBCs from the very beginning of the storage period, to maintain their quality. Leukoreduced CPD-SAGM RBC concentrates were supplemented with 416 µM uric acid and 114 µM ascorbic acid and stored during six weeks at 4 °C. Different markers, i.e., haematological parameters, metabolism, sensitivity to oxidative stress, morphology and haemolysis were analyzed. Quantitative metabolomic analysis of targeted intracellular metabolites demonstrated a direct modification of several metabolite levels following antioxidant supplementation. No significant differences were observed for the other markers. In conclusion, the results obtained show that uric and ascorbic acids supplementation partially prevented the metabolic shift triggered by plasma depletion that occurs during the RBC concentrate preparation. The treatment directly and indirectly sustains the antioxidant protective system of the stored RBCs.

Indexed as

antioxidantascorbic acidblood storagemetabolomicsred blood celltransfusionuric acid

Identifiers

PMID32486030
PMCPMC7344535
OpenAlexW3031867929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.